The global Sickle Cell Anemia Treatment Market is expected to reach USD 10.96 Biliion by the end of 2032, with a valuation of USD 8.78 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 2.5%.